Faeth Therapeutics, Inc. (FTH)
NASDAQ · Manufacturing · Pharmaceutical preparations
FTH price, last 12 months
Key stats
- Previous close
- $8.72
- Open
- $8.73
- Day range
- $8.54 – $9.21
- 52-week range
- $7.84 – $42.14
- Volume
- 470.8K
- Avg volume (20 days)
- 751.2K
- Market cap
- $259.2M
Performance
Technicals and fundamentals
About Faeth Therapeutics, Inc.
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $259.2M